Evidence map›Paper›PMID 42059197›Full record

ArticleEuropean journal of neurology2026

A Population-Based Study of Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome During Pregnancy and Puerperium.

Vest Teresa, Verho Liisa, Rantanen Kirsi, Aarnio Karoliina, Korhonen Aino, Richardt Anna, Gissler Mika, Tikkanen Minna, Laivuori Hannele, Ijäs Petra

Erratum issuedAbstract read
In one paragraph

Article in European journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Vest TeresaDepartment of Neurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.ORCID https://orcid.org/0000-0003-0698-4824
Verho LiisaObstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Rantanen KirsiDepartment of Neurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Aarnio KaroliinaDepartment of Neurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Korhonen AinoDepartment of Neurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Richardt AnnaDepartment of Neurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Gissler MikaDepartment of Data and Analytics, Finnish Institute for Health and Welfare, Helsinki, Finland.ORCID https://orcid.org/0000-0001-8254-7525
Tikkanen MinnaObstetrics and Gynecology, University of Helsinki, Helsinki, Finland.
Laivuori HanneleMedical and Clinical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.ORCID https://orcid.org/0000-0003-3212-7826
Ijäs PetraDepartment of Neurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Funding

Maire Taposen SäätiöNeurocenter, Helsinki University HospitalState Research FundSuomen Aivosäätiö 20240073Svenska Kulturfonden 210836Waldemar von Frenckells Stiftelse
6 · The paper itself

Abstract

backgroundPosterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) are related neurovascular conditions, with pregnancy as a shared risk factor. In this study, we aimed to describe shared and distinctive risk factors and outcomes in patients with pregnancy-associated PRES and/or RCVS.

methodsIn this retrospective, nationwide, population-based cohort study, the national healthcare registers were utilized to identify women with PRES and/or RCVS during pregnancy or puerperium during 1987-2016. Subsequent pregnancies, vascular events, and deaths until 2022 were identified. Medical records were reviewed to classify cerebrovascular events and collect clinical details.

resultsIn total, 27 patients had pregnancy-associated PRES and/or RCVS (18 PRES; 5 PRES + RCVS; 4 RCVS) during 1987-2016, resulting in an incidence of 1.52 per 100,000 (95% Cl 1.02-2.18) deliveries. All patients with PRES ± RCVS had preeclampsia with severe features during late pregnancy or early puerperium. In contrast, isolated RCVS showed a weaker association to preeclampsia and occurred in late puerperium, with a median puerperal day of 26 (IQR 11-45). Altogether, 40.7% of all patients had a stroke, 90.9% of which were hemorrhagic. Preeclampsia was diagnosed in 90.9% of stroke patients. Maternal mortality was 3.7%, whereas perinatal mortality was 7.4%. At 3 months, 92.3% had a good recovery (mRS 0-2). During follow-up, stroke recurrence was 3.7% and 33.3% had subsequent uneventful, full-term pregnancies.

conclusionsPregnancy-associated PRES and RCVS are potentially life-threatening, rare conditions that can result in hemorrhagic stroke. PRES ± RCVS is strongly associated with preeclampsia with severe features, whereas puerperal RCVS seems to be a separate, later-occurring condition.

Indexed as

Cerebrovascular DisordersPosterior Leukoencephalopathy SyndromePregnancy Complications, CardiovascularPuerperal DisordersVasospasm, IntracranialAdultFemaleHumansPostpartum PeriodPre-EclampsiaPregnancyRegistriesRetrospective StudiesRisk Factorscerebrovascular disorderspreeclampsiapregnancypuerperiumstroke

Identifiers

PMID42059197
PMCPMC13129962

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.